PMID: 8864643Jul 1, 1996Paper

Role of elevated lipids in diabetic cardiomyopathy

Diabetes Research and Clinical Practice
J H McNeill

Abstract

Diabetic cardiac dysfunction appears to be associated with an increase in plasma lipids especially triglycerides. Drugs that lower plasma lipids will usually improve cardiac performance in diabetic rats. More recently, an association between decreased cardiac glucose metabolism resulting from increased utilization of fatty acid metabolism in the diabetic myocardium has been suggested. Of the drugs tested, those drugs that decreased plasma lipids and improved cardiac glucose metabolism also improved cardiac performance. Drugs, such as clofibrate, which decreased triglyceride levels and did not enhance cardiac performance in diabetic rats will be examined in the near future in order to test the hypothesis.

References

Oct 1, 1992·Cardiovascular Research·B Rodrigues, J H McNeill
Aug 1, 1990·Canadian Journal of Physiology and Pharmacology·B RodriguesJ H McNeill
Aug 1, 1985·Canadian Journal of Physiology and Pharmacology·A G Tahiliani, J H McNeill
Jan 1, 1995·Journal of Molecular and Cellular Cardiology·B RodriguesJ H McNeill
May 1, 1994·Canadian Journal of Physiology and Pharmacology·B RodriguesJ H McNeill

❮ Previous
Next ❯

Citations

May 25, 2006·The Biochemical Journal·Neslihan ToyranFeride Severcan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.